Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For NEO
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 20.72 7.48 6.20
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -10.30 -27.90 31.10
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.07 7.32 7.48
Cash -7.45 3.05 3.30
Capex 20.97 -0.04 -0.06
Free Cash Flow 193.23 -0.25 0.09
Revenue 0.30 1.24 1.24
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -8.65 0.40 0.43
Operating Margin -50.99 -0.18 -0.12
ROA -93.60 -0.02 < 0.005
ROE -92.60 -0.03 -0.02
ROIC -67.51 -0.02 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of NEO is permitted for members.
5 Growth
The "Growth Entry" for the Focus of NEO is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of NEO is permitted for members.